Barbara Gilchrest

Summary

Affiliation: Boston University
Country: USA

Publications

  1. ncbi Using DNA damage responses to prevent and treat skin cancers
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    J Dermatol 31:862-77. 2004
  2. ncbi The tale of the telomere: implications for prevention and treatment of skin cancers
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Investig Dermatol Symp Proc 10:124-30. 2005
  3. ncbi Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells
    Mina Yaar
    Department of Dermatology, Boston University School of Medicine, Albany Street, Boston, MA 02118 2394, USA
    Breast Cancer Res 9:R13. 2007
  4. ncbi Telomere-mediated effects on melanogenesis and skin aging
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA
    J Investig Dermatol Symp Proc 14:25-31. 2009
  5. ncbi Sun protection and Vitamin D: three dimensions of obfuscation
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street J507, Boston, MA 02118, USA
    J Steroid Biochem Mol Biol 103:655-63. 2007
  6. ncbi Sun exposure and vitamin D sufficiency
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, Boston, MA, USA
    Am J Clin Nutr 88:570S-577S. 2008
  7. ncbi Fate of melanocytes during development of the hair follicle pigmentary unit
    Natalia V Botchkareva
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    J Investig Dermatol Symp Proc 8:76-9. 2003
  8. ncbi A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage
    Dany Touma
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118-2394, USA
    Arch Dermatol 140:33-40. 2004
  9. ncbi Modulation of vascular endothelial growth factor receptors in melanocytes
    Ellen J Kim
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    Exp Dermatol 14:625-33. 2005
  10. ncbi Bone morphogenetic protein-4, a novel modulator of melanogenesis
    Mina Yaar
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Biol Chem 281:25307-14. 2006

Research Grants

  1. Telomere homolog oligonucleotides for cancer therapy
    Barbara Gilchrest; Fiscal Year: 2004
  2. MELANOMA CONTROL FOR SIBLING OF MELANOMA PATIENTS
    Barbara Gilchrest; Fiscal Year: 2001
  3. Telomere-Mediated Protective Responses in Skin
    Barbara Gilchrest; Fiscal Year: 2007

Detail Information

Publications72

  1. ncbi Using DNA damage responses to prevent and treat skin cancers
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    J Dermatol 31:862-77. 2004
  2. ncbi The tale of the telomere: implications for prevention and treatment of skin cancers
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Investig Dermatol Symp Proc 10:124-30. 2005
    ..The ability of T-oligo treatment to trigger SOS-like responses and/or to cause selective apoptosis of already malignantly transformed cells may provide an important new means of cancer prevention and treatment...
  3. ncbi Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells
    Mina Yaar
    Department of Dermatology, Boston University School of Medicine, Albany Street, Boston, MA 02118 2394, USA
    Breast Cancer Res 9:R13. 2007
    ....
  4. ncbi Telomere-mediated effects on melanogenesis and skin aging
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts, USA
    J Investig Dermatol Symp Proc 14:25-31. 2009
    ..Journal of Investigative Dermatology Symposium Proceedings (2009) 14, 25-31; doi:10.1038/jidsymp.2009.9...
  5. ncbi Sun protection and Vitamin D: three dimensions of obfuscation
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street J507, Boston, MA 02118, USA
    J Steroid Biochem Mol Biol 103:655-63. 2007
    ..The medical community should avoid sensationalism and instead rigorously explore possible cause-and-effect relationships between vit D status and specific diseases while advocating the safest possible means of assuring vit D sufficiency...
  6. ncbi Sun exposure and vitamin D sufficiency
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, Boston, MA, USA
    Am J Clin Nutr 88:570S-577S. 2008
    ..Instead, they should rigorously explore possible cause-and-effect relations between vitamin D(3) status and specific diseases while advocating the safest possible means of ensuring vitamin D(3) sufficiency...
  7. ncbi Fate of melanocytes during development of the hair follicle pigmentary unit
    Natalia V Botchkareva
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    J Investig Dermatol Symp Proc 8:76-9. 2003
    ....
  8. ncbi A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage
    Dany Touma
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118-2394, USA
    Arch Dermatol 140:33-40. 2004
    ..Further studies with a larger cohort, longer follow-up, and histologic confirmation of the clinical data would be of value...
  9. ncbi Modulation of vascular endothelial growth factor receptors in melanocytes
    Ellen J Kim
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    Exp Dermatol 14:625-33. 2005
    ..Prolonged culture (>8 weeks) in the presence of phorbol ester abrogates VEGFR-2 expression, explaining previous reports that Mc do not express VEGFR-1 and VEGFR-2. These data suggest that VEGF may play a role in Mc behavior in skin...
  10. ncbi Bone morphogenetic protein-4, a novel modulator of melanogenesis
    Mina Yaar
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Biol Chem 281:25307-14. 2006
    ..Our data provide evidence of a novel regulatory pathway for melanogenesis in human skin...
  11. ncbi Tyrosinase gene expression is regulated by p53
    Mary K Khlgatian
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Invest Dermatol 118:126-32. 2002
    ..The data further suggest that tanning is part of a p53-mediated adaptive response of mammalian skin to DNA damage from ultraviolet irradiation...
  12. ncbi Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation
    Andrei A Sharov
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118, USA
    EMBO J 22:2992-3003. 2003
    ..These data suggest that the BMP signaling pathway plays an important role in regulation of genetic programs of eyelid opening and skin remodeling during the final steps of eye morphogenesis...
  13. ncbi The interdependence of skin aging, skin cancer, and DNA repair capacity: a novel perspective with therapeutic implications
    David A Goukassian
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    Rejuvenation Res 7:175-85. 2004
    ..This review focuses predominantly on UV-induced DNA damage in human skin, protective molecular responses to UV damage, and the consequences of these opposing forces for aging and photocarcinogenesis...
  14. ncbi T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter
    Vaneeta Marwaha
    Department of Dermatology, Boston University School of Medicine, Massachusetts 02118, USA
    J Biol Chem 280:32379-88. 2005
    ..Decreased COX-2 expression may contribute to the observed ability of T-oligos to reduce photocarcinogenesis...
  15. ncbi Detection of UV-induced pigmentary and epidermal changes over time using in vivo reflectance confocal microscopy
    Maritza A Middelkamp-Hup
    Wellman Laboratories of Photomedicine, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Invest Dermatol 126:402-7. 2006
    ..This technique should greatly enhance our appreciation of dynamic pigmentary changes in human or animal skin over time and in response to specific stimuli...
  16. ncbi The vitamin D questions: how much do you need and how should you get it?
    Deon Wolpowitz
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Am Acad Dermatol 54:301-17. 2006
    ....
  17. ncbi Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation
    Hee Young Park
    Department of Dermatology, Boston University School of Medicine, Massachusetts 02118, USA
    J Invest Dermatol 122:159-66. 2004
    ..These results demonstrate that inhibiting PKC activity in vivo selectively blocks tanning and reduces basal pigmentation in the epidermis and in anagen hair shafts...
  18. ncbi Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice
    Simin Arad
    Department of Dermatology, Boston University School of Medicine, 609 Albany St, Boston, MA 02118, USA
    Am J Pathol 172:1248-55. 2008
    ..01). We conclude that topical pTT treatment during a prolonged period of intermittent UV exposure decreases the number and size of UV-induced BCCs through several anti-cancer mechanisms...
  19. ncbi The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes
    Hee Young Park
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118, USA
    J Cell Sci 117:3659-68. 2004
    ..Taken together, these results demonstrate that RACK-I anchors activated PKC-beta on the melanosome membrane, allowing PKC-beta to phosphorylate tyrosinase...
  20. ncbi A randomized trial to improve early detection and prevention practices among siblings of melanoma patients
    Alan C Geller
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Cancer 107:806-14. 2006
    ..The first-degree relatives of melanoma patients represent a risk group who may experience a 'teachable moment' for enhanced education and risk reduction...
  21. ncbi Telomere-based DNA damage responses: a new approach to melanoma
    Neelu Puri
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118-2394, USA
    FASEB J 18:1373-81. 2004
    ..We suggest that T-oligo mimics a physiologic DNA damage signal that is frequently masked in malignant cells and thereby activates innate cancer prevention responses. T-oligos may provide a novel therapeutic approach to melanoma...
  22. ncbi Fas signaling is involved in the control of hair follicle response to chemotherapy
    Andrei A Sharov
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Cancer Res 64:6266-70. 2004
    ..These data raise a possibility to explore blockade of Fas signaling as a part of complex local therapy for inhibiting keratinocyte apoptosis and hair loss induced by chemotherapy...
  23. ncbi Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice
    David A Goukassian
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    Proc Natl Acad Sci U S A 101:3933-8. 2004
    ..The ability of topically applied pTT to induce protective physiologic responses that normally result from DNA damage suggests a previously undescribed means of reducing skin cancer in high-risk individuals...
  24. ncbi A role for WRN in telomere-based DNA damage responses
    Mark S Eller
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118, USA
    Proc Natl Acad Sci U S A 103:15073-8. 2006
    ..The T-oligo model helps define the role of WRN in telomere maintenance and initiation of DNA damage responses after telomere disruption...
  25. ncbi T-oligos augment UV-induced protective responses in human skin
    Simin Arad
    Department of Dermatology, Boston University School of Medicine, 609 Albany St, Boston, MA 02118, USA
    FASEB J 20:1895-7. 2006
    ....
  26. ncbi Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin-1 receptor expression in the hair follicle
    Ruzanna Y Atoyan
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    Exp Dermatol 16:671-7. 2007
    ..These data demonstrate that pTT treatment increases eumelanogenesis in HFs, associated with increased tyrosinase, TRP-1 and MC-1R expression. These data also raise the possibility of using T-oligos to modulate hair pigmentation...
  27. ncbi UV induces VEGF through a TNF-alpha independent pathway
    Maria G Kosmadaki
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    FASEB J 17:446-8. 2003
    ..Our results suggest that VEGF induction after UV irradiation is mediated by multiple mechanisms and that blocking a single pathway does not affect the response...
  28. ncbi Should the skin cancer examination be taught in medical school?
    Alan C Geller
    Department of Dermatology, Boston University School of Medicine, 720 Harrison Ave, DOB801A, Boston, MA 02118, USA
    Arch Dermatol 138:1201-3. 2002
    ..We documented the antecedents of physician practice by evaluating medical students' observation, training, performance, and self-reported skill level for the skin cancer examination and sun protection counseling...
  29. ncbi Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program
    Alan C Geller
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Cancer 95:1554-61. 2002
    ..In the current study, the authors sought to identify factors associated with a high yield in skin cancer screening and to explore strategies for improving mass screenings for melanoma...
  30. ncbi The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999
    Alan C Geller
    Department of Dermatology, Boston University School of Medicine, Massachusetts 02118, USA
    J Am Acad Dermatol 48:34-41. 2003
    ..The purpose of this analysis is to investigate the risk factors, access to dermatologic services, and screening results of participants in AAD-sponsored programs during the first 15 years that this service was available to the US public...
  31. ncbi Modulations of nerve growth factor and Bcl-2 in ultraviolet-irradiated human epidermis
    Catherine M Stefanato
    Section of Dermatopathology, Boston University School of Medicine, Boston, MA, USA
    J Cutan Pathol 30:351-7. 2003
    ..The purpose of this study was to determine NGF and Bcl-2 modulations in UV-irradiated human skin...
  32. ncbi Topical photodynamic therapy: a new tool in cosmetic dermatology
    Dany J Touma
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    Semin Cutan Med Surg 22:124-30. 2003
    ..This article reviews recent advances in this field, with emphasis on skin rejuvenation, acne, and hair removal...
  33. ncbi Quantification of inducible SOS-like photoprotective responses in human skin
    Simin Arad
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Invest Dermatol 127:2629-36. 2007
    ..These data confirm and quantify comparable SOS-like responses in human skin after pTT or UV irradiation, attributable to both increased epidermal melanin and increased DNA repair rate, in the case of pTT in the absence of initial damage...
  34. ncbi Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) hair follicles
    Vladimir A Botchkarev
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Invest Dermatol 118:3-10. 2002
    ..This suggests that regulation of BMP2/4 signaling by noggin is essential for the induction of secondary hair follicles, as well as for advanced stages of development in primary hair follicles...
  35. ncbi Inhibition of the elicitation phase of contact hypersensitivity by thymidine dinucleotides is in part mediated by increased expression of interleukin-10 in human keratinocytes
    Clara Curiel-Lewandrowski
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118-2394, USA
    Exp Dermatol 12:145-52. 2003
    ..Finally, regardless of mechanism, the data suggest that topical treatment with pTpT may provide a novel means of suppressing contact hypersensitivity or other lymphocyte-mediated reactions in skin...
  36. ncbi Skin cancer prevention and detection practices among siblings of patients with melanoma
    Alan C Geller
    Boston University School of Medicine, Department of Dermatology, Boston, MA 02118, USA
    J Am Acad Dermatol 49:631-8. 2003
    ..These statistics suggest that first-degree relatives of patients with melanoma, who are at particularly high risk, warrant targeted public health action...
  37. ncbi MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes
    Hee Young Park
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street J 205, Boston, MA 02118 2394, USA
    Biochem J 395:571-8. 2006
    ..Together, these results demonstrate that MITF, specifically MITF-M, is a key transcription factor for PKC-beta, linking the PKC- and cAMP-dependent pathways in regulation of melanogenesis...
  38. ncbi Visual screening for malignant melanoma: a cost-effectiveness analysis
    Elena Losina
    Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA
    Arch Dermatol 143:21-8. 2007
    ..To evaluate the cost-effectiveness of various melanoma screening strategies proposed in the United States...
  39. ncbi Skin aging 2003: recent advances and current concepts
    Barbara A Gilchrest
    Department of Dermatology, Boston University School of Medicine, Massachusetts, USA
    Cutis 72:5-10; discussion 10. 2003
    ..Still, within a relatively short time, there has been tremendous progress, a progress greatly enhanced by basic gerontologic research using immunologic, biochemical, and in particular, molecular biologic approaches...
  40. ncbi DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity
    David A Goukassian
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    FASEB J 16:754-6. 2002
    ..Our studies suggest that topical oligonucleotide treatment may enhance DRC in older adults and thus reduce the carcinogenic risk from solar UV irradiation in this age group...
  41. ncbi Induction of apoptosis by telomere 3' overhang-specific DNA
    Mark S Eller
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118-2394, USA
    Exp Cell Res 276:185-93. 2002
    ....
  42. ncbi delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome
    Aleksandr Itkin
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Dermatol Surg 30:1054-61. 2004
    ..To our knowledge, the blue light source (417 nm peak irradiance) approved by the FDA for treatment of actinic keratoses has not been used for photodynamic therapy with delta-aminolevulinic acid of basal cell carcinoma...
  43. ncbi Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells
    Norio Ohashi
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118 2394, USA
    J Cell Physiol 210:582-95. 2007
    ....
  44. ncbi Fifty years of skin aging
    Mina Yaar
    Boston University School of Medicine, Department of Dermatology, 609 Albany Street, Boston, Massachusetts 02118-2394, USA
    J Investig Dermatol Symp Proc 7:51-8. 2002
    ..Still, within this relatively short time there has been tremendous progress, a progress greatly enhanced by basic gerontologic research employing immunologic, biochemical, and particularly molecular biologic approaches (Figs 1, 2)...
  45. ncbi Photoprotection in human skin--a multifaceted SOS response
    Mark S Eller
    Department of Dermatology, Boston University School of Medicine, Boston, MA, USA
    Photochem Photobiol 84:339-49. 2008
    ....
  46. ncbi Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage
    Margaret S Lee
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    J Dermatol Sci 56:154-62. 2009
    ..Telomere homolog oligonucleotides (T-oligos) induce adaptive DNA damage responses including increased DNA repair capacity and these effects are mediated, at least in part, through p53...
  47. ncbi Evidence that exposure of the telomere 3' overhang sequence induces senescence
    Guang-Zhi Li
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street, J-Building, Boston, MA 02118-2394, USA
    Proc Natl Acad Sci U S A 100:527-31. 2003
    ..We further demonstrate that these responses can be induced by treatment with oligonucleotides homologous to the overhang in the absence of telomere disruption, a phenomenon of potential therapeutic importance...
  48. ncbi Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss
    Andrei A Sharov
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Invest Dermatol 120:27-35. 2003
    ..Pharmacologic manipulation of Fas and c-kit signaling pathways might be useful for the correction of skin hyperpigmentation as a side-effect of chemotherapy...
  49. ncbi Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway
    Andrey A Sharov
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118, USA
    Proc Natl Acad Sci U S A 102:93-8. 2005
    ....
  50. ncbi Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides
    Guang-Zhi Li
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118-2394, USA
    Exp Cell Res 301:189-200. 2004
    ....
  51. ncbi If it's not the hamburgers, it's the sunscreens
    Barbara A Gilchrest
    Boston, Massachusetts, USA
    J Invest Dermatol 123:xi-xii. 2004
  52. ncbi Biology of estrogens in skin: implications for skin aging
    Sylvie Verdier-Sévrain
    Department of Dermatology, Boston University School of Medicine, Boston, MA, USA
    Exp Dermatol 15:83-94. 2006
    ..These drugs exert mixed estrogenic and antiestrogenic effects depending on the tissue and cell type. One might expect in the future such a drug targeting specifically the skin without systemic side effects...
  53. ncbi Melanocyte biology: before, during, and after the Fitzpatrick era
    Mina Yaar
    Boston University School of Medicine, Boston, Massachusetts, USA
    J Invest Dermatol 122:xxvii-xxix. 2004
  54. ncbi Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling
    Mina Yaar
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Biol Chem 277:7720-5. 2002
    ..Our data suggest that p75(NTR) may be present as a preformed trimer that binds amyloid beta to induce receptor activation, and support the hypothesis that p75(NTR) activation by amyloid beta is causally related to Alzheimer's disease...
  55. ncbi p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation
    Mina Yaar
    Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA
    Cell Mol Neurobiol 28:1027-31. 2008
    ..These data suggest that blocking the binding of Abeta to p75(NTR) may reduce neuronal loss in Alzheimer's disease...
  56. ncbi Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA
    Mark S Eller
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118-2394, USA
    FASEB J 17:152-62. 2003
    ....
  57. ncbi Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential
    Harold O Longe
    Department of Medicine, Cancer Research Center, Boston University School of Medicine BUSM, Boston, MA 02118, USA
    Int J Cancer 124:473-82. 2009
    ..Thus, T-oligo sensitizes tumors to traditional anticancer agents and represents a potentially important new addition to the therapeutic arsenal for aggressive lymphomas...
  58. ncbi Academic dermatology manpower: issues of recruitment and retention
    Daniel S Loo
    Department of Dermatology, Boston University School of Medicine, Boston, Mass 02118, USA
    Arch Dermatol 143:341-7. 2007
    ..To assess the total number, recruitment rate, departure rate, and growth rate of full-time academic dermatologists in the United States over the last decade...
  59. ncbi More on MITF
    Hee-Young Park
    Boston University School of Medicine, Boston, MA, USA
    J Invest Dermatol 119:1218-9. 2002
  60. ncbi Obstacles to translation conference
    Ervin H Epstein
    Department of Dermatology, University of California, San Francisco, California, USA
    J Invest Dermatol 126:1434-7. 2006
  61. ncbi p75 Neurotrophin receptor antagonist retards apoptosis-driven hair follicle involution (catagen)
    Vladimir A Botchkarev
    J Invest Dermatol 120:168-9. 2003
  62. ncbi Solar-simulated irradiation evokes a persistent and biphasic IL-1alpha response
    Dan Luo
    Nanjing Medical University, Department of Dermatology, Nanjing 210029, China
    Exp Dermatol 13:11-7. 2004
    ..Our study provides evidence that UV-induced adaptive cutaneous responses persist for at least several days, and suggests that different mechanisms may mediate the early vs. late inductions...
  63. ncbi Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome
    Anne M Chapas
    Laser and Skin Surgery Center of New York, New York, NY 10016, USA
    J Drugs Dermatol 5:3-5. 2006
    ..This treatment strategy resulted in multiple benefits, including reducing the number and size of his existing basal cell carcinomas, improving the appearance of previous surgical scars, and decreasing the rate of tumor development...
  64. ncbi A call for the development and implementation of a targeted national melanoma screening program
    Alan C Geller
    Arch Dermatol 142:504-7. 2006
  65. ncbi Improving skin cancer prevention and detection education in US medical schools
    Heather A Brandling-Bennett
    Arch Dermatol 142:524-6. 2006
  66. ncbi Effect of sunscreen application on UV-induced thymine dimers
    Mona Al Mahroos
    Department of Dermatology, Salmaniya Medical Complex, Manama, Bahrain
    Arch Dermatol 138:1480-5. 2002
    ..Irregular and inadequate use of sunscreen during exposure to UV radiation results in thymine dimer formation, which may lead to mutation and subsequent cancer development...
  67. ncbi Skin cancer examination teaching in US medical education
    Megan M Moore
    Harvard Medical School, USA
    Arch Dermatol 142:439-44. 2006
    ..More frequent and improved SCEs might result in earlier detection of melanoma and nonmelanoma skin cancers by nondermatologists, with significant public health benefits...
  68. ncbi Sunlight, tanning booths, and vitamin D
    Henry W Lim
    Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 52:868-76. 2005
  69. ncbi Photosensitivity dermatitis from inadvertent exposure to aminolevulinic acid
    Ross Zeltser
    Cutis 80:124. 2007
  70. ncbi Psychosocial aspects of aging skin
    Madhulika A Gupta
    Department of Psychiatry, University of Western Ontario, London, Canada
    Dermatol Clin 23:643-8. 2005
    ..Patients should therefore be offered treatments for aging skin, ensured that society's negative views not be unnecessarily reinforced, and maintain a realistic treatment expectations...
  71. ncbi The demographics of aging in the United States: implications for dermatology
    Maria G Kosmadaki
    Arch Dermatol 138:1427-8. 2002
  72. ncbi Melanoma incidence and mortality among US whites, 1969-1999
    Alan C Geller
    JAMA 288:1719-20. 2002

Research Grants10

  1. Telomere homolog oligonucleotides for cancer therapy
    Barbara Gilchrest; Fiscal Year: 2004
    ..abstract_text> ..
  2. MELANOMA CONTROL FOR SIBLING OF MELANOMA PATIENTS
    Barbara Gilchrest; Fiscal Year: 2001
    ....
  3. Telomere-Mediated Protective Responses in Skin
    Barbara Gilchrest; Fiscal Year: 2007
    ..The studies will also explore the possible therapeutic potential of T-oligos that comparably induce these responses in the absence of actual DNA damage or telomere disruption. ..